Even at very high prostate-specific antigen (PSA) values, roughly 5% of PSMA-PET/CT scans are negative due to PSMA-negative disease, possibly as a result of tumour dedifferentiation [23, 24]. This evidence concerns the gene FOLH1 and neoplasm.